Search

everythinglearnresearchcommunity

for

Search:↓

Certain genes and nutrients like vitamin D, zinc, and omega fatty acids affect COVID-19 severity and infection risk.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

Hydroxychloroquine, nitazoxanide, and ivermectin were similarly effective in treating early COVID-19.

Most severe COVID-19 patients in Mexico experienced long-lasting symptoms that worsened their quality of life.

The COVID-19 pandemic increased the use of teledermatology to treat skin conditions in low-income areas, despite challenges like poor photo quality.

COVID-19 can cause hair loss and nail issues, with treatments available for these conditions.

COVID-19 can cause hair loss, and treatments like PRP and stem cells might help.

The study concluded that different treatments reduced post-COVID symptoms over time and that factors like age, severity, and comorbidities affect symptom risk.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

Many people in Saudi Arabia experienced hair loss after COVID-19, especially women, those treated with antivirals, and those with a history of hair shedding.

One-third of COVID-19 patients had long-term symptoms like hair loss and fatigue, with women, older individuals, blood group B, smokers, and those with more virus exposure at higher risk.

Early treatment with certain drug combinations improved COVID-19 outcomes and prevented severe disease in males, including those at higher risk.

Men with male pattern baldness had worse COVID-19 symptoms, but early treatment with certain drugs improved outcomes for all.

Many COVID-19 survivors continue to experience symptoms like fatigue and concentration problems after recovery, possibly needing rehabilitation.

Kidney transplant patients who had COVID-19 experienced a significant drop in their quality of life due to long-lasting symptoms.

The COVID-19 pandemic led to fewer patient visits, more visits by older adults, an increase in cutaneous T-cell lymphoma cases, and a rise in noncosmetic procedures at a dermatology clinic.

Early treatment improved COVID-19 outcomes, and spironolactone helped reduce risks in females with high androgen levels.

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.

Testosterone's effects on COVID-19 are unclear and need more research.

MAIT cells may help fight COVID-19 but also contribute to severe inflammation.

Antiandrogens might help prevent or treat COVID-19 by blocking the virus's entry into cells.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

Four drugs were found that could potentially treat COVID-19 by inhibiting the virus in lab tests.

Social media data can help track COVID-19 symptoms and predict the pandemic's status.

More people experience hair loss after recovering from COVID-19 in hospitals than in outpatient settings.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

Mice with a virus similar to COVID-19 had skin damage, but a special treatment helped repair it.

COVID-19 may cause temporary hair loss, which usually gets better on its own, but reducing stress and managing health issues might help recovery.